View Clinical Trial (Medical Research Study)
10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus - NCT00568997-(Clinical Trial 193647)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Pennsylvania |
|
State:
|
|
PA |
| Zip Code: |
|
|
| Conditions: |
|
Atopic Dermatitis |
| Purpose: |
|
This study will examine the incidence of lymphoma in pediatric subjects who have been
exposed to pimecrolimus 1% cream.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- males and females
- greater than or equal to 2 years and less than or equal to 17 years at enrollment
- diagnosis of atopic dermatitis (confirmed by treating physician)
- applied pimecrolimus cream 1 % 6 weeks out of past 24 weeks
Exclusion Criteria:
- past or present history of systemic malignancy, skin malignancy, or
lymphoproliferative disease
- past or present use of oral immunosuppressive therapy
Other protocol-defined inclusion/exclusion criteria may apply |
|
|
|
| Study is available at: |
|
Registry
Pennsylvania, PA
United States
Primary Contact:
Novartis NA Pharma
Phone: 862-778-8300 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 22, 2011 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|